Bioluminescence immunoassay for angiotensin II using aequorin as a label

Xiaoge Qu, Sapna K Deo, Emre Dikici, Mark Ensor, Michael Poon, Sylvia Daunert

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Angiotensin II is a biologically active component of the renin-angiotensin system. High levels of angiotensin II may be responsible for hypertension and heart failure because they increase systemic vascular resistance, arterial pressure, and sodium and fluid retention. Therefore, it is important to monitor angiotensin II levels for the treatment of hypertension and heart diseases. The goal of this work was to develop a bioluminescence immunoassay using aequorin as a label to measure angiotensin II levels in human plasma. This method utilizes a genetically engineered fusion protein between angiotensin II and aequorin. For that, the C terminus of angiotensin II was fused to the N terminus of apoaequorin using molecular biology techniques. A heterogeneous immunoassay was then developed for the determination of angiotensin II. A detection limit of 1 pg/mL was obtained with the optimized assay, allowing for the determination of angiotensin II at physiological levels in human plasma.

Original languageEnglish
Pages (from-to)154-161
Number of pages8
JournalAnalytical Biochemistry
Volume371
Issue number2
DOIs
StatePublished - Dec 15 2007
Externally publishedYes

Fingerprint

Aequorin
Bioluminescence
Immunoassay
Angiotensin II
Labels
Plasma (human)
Hypertension
Molecular biology
Angiotensins
Renin-Angiotensin System
Renin
Vascular Resistance
Limit of Detection
Molecular Biology
Heart Diseases
Assays
Arterial Pressure
Fusion reactions
Heart Failure
Sodium

Keywords

  • Aequorin
  • Angiotensin II
  • Bioluminescence immunoassay
  • Reporter protein

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Bioluminescence immunoassay for angiotensin II using aequorin as a label. / Qu, Xiaoge; Deo, Sapna K; Dikici, Emre; Ensor, Mark; Poon, Michael; Daunert, Sylvia.

In: Analytical Biochemistry, Vol. 371, No. 2, 15.12.2007, p. 154-161.

Research output: Contribution to journalArticle

Qu, Xiaoge ; Deo, Sapna K ; Dikici, Emre ; Ensor, Mark ; Poon, Michael ; Daunert, Sylvia. / Bioluminescence immunoassay for angiotensin II using aequorin as a label. In: Analytical Biochemistry. 2007 ; Vol. 371, No. 2. pp. 154-161.
@article{33b739a49fc143de86e02212d89d31df,
title = "Bioluminescence immunoassay for angiotensin II using aequorin as a label",
abstract = "Angiotensin II is a biologically active component of the renin-angiotensin system. High levels of angiotensin II may be responsible for hypertension and heart failure because they increase systemic vascular resistance, arterial pressure, and sodium and fluid retention. Therefore, it is important to monitor angiotensin II levels for the treatment of hypertension and heart diseases. The goal of this work was to develop a bioluminescence immunoassay using aequorin as a label to measure angiotensin II levels in human plasma. This method utilizes a genetically engineered fusion protein between angiotensin II and aequorin. For that, the C terminus of angiotensin II was fused to the N terminus of apoaequorin using molecular biology techniques. A heterogeneous immunoassay was then developed for the determination of angiotensin II. A detection limit of 1 pg/mL was obtained with the optimized assay, allowing for the determination of angiotensin II at physiological levels in human plasma.",
keywords = "Aequorin, Angiotensin II, Bioluminescence immunoassay, Reporter protein",
author = "Xiaoge Qu and Deo, {Sapna K} and Emre Dikici and Mark Ensor and Michael Poon and Sylvia Daunert",
year = "2007",
month = "12",
day = "15",
doi = "10.1016/j.ab.2007.08.038",
language = "English",
volume = "371",
pages = "154--161",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Bioluminescence immunoassay for angiotensin II using aequorin as a label

AU - Qu, Xiaoge

AU - Deo, Sapna K

AU - Dikici, Emre

AU - Ensor, Mark

AU - Poon, Michael

AU - Daunert, Sylvia

PY - 2007/12/15

Y1 - 2007/12/15

N2 - Angiotensin II is a biologically active component of the renin-angiotensin system. High levels of angiotensin II may be responsible for hypertension and heart failure because they increase systemic vascular resistance, arterial pressure, and sodium and fluid retention. Therefore, it is important to monitor angiotensin II levels for the treatment of hypertension and heart diseases. The goal of this work was to develop a bioluminescence immunoassay using aequorin as a label to measure angiotensin II levels in human plasma. This method utilizes a genetically engineered fusion protein between angiotensin II and aequorin. For that, the C terminus of angiotensin II was fused to the N terminus of apoaequorin using molecular biology techniques. A heterogeneous immunoassay was then developed for the determination of angiotensin II. A detection limit of 1 pg/mL was obtained with the optimized assay, allowing for the determination of angiotensin II at physiological levels in human plasma.

AB - Angiotensin II is a biologically active component of the renin-angiotensin system. High levels of angiotensin II may be responsible for hypertension and heart failure because they increase systemic vascular resistance, arterial pressure, and sodium and fluid retention. Therefore, it is important to monitor angiotensin II levels for the treatment of hypertension and heart diseases. The goal of this work was to develop a bioluminescence immunoassay using aequorin as a label to measure angiotensin II levels in human plasma. This method utilizes a genetically engineered fusion protein between angiotensin II and aequorin. For that, the C terminus of angiotensin II was fused to the N terminus of apoaequorin using molecular biology techniques. A heterogeneous immunoassay was then developed for the determination of angiotensin II. A detection limit of 1 pg/mL was obtained with the optimized assay, allowing for the determination of angiotensin II at physiological levels in human plasma.

KW - Aequorin

KW - Angiotensin II

KW - Bioluminescence immunoassay

KW - Reporter protein

UR - http://www.scopus.com/inward/record.url?scp=35548977565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548977565&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2007.08.038

DO - 10.1016/j.ab.2007.08.038

M3 - Article

C2 - 17931588

AN - SCOPUS:35548977565

VL - 371

SP - 154

EP - 161

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 2

ER -